Chugai Pharma Europe Ltd and Chugai Pharma UK Ltd believe it is important to be transparent regarding interactions with Healthcare Professionals, Healthcare Organisations, the NHS and with Patient Organisations.

• Payments made to Healthcare Professionals and Healthcare Organisations will be disclosed via central portals organised and managed by The Irish Pharmaceutical Healthcare Association (IPHA) and The Association of the British Pharmaceutical Industry (ABPI) for payments made in Ireland and the UK respectively. These payments have been publicly available since 1st July 2016 and are updated annually. The Chugai methodological notes listed below will give support to any reader to better understand the manner in which Chugai manages such payments.
• The NHS and the pharmaceutical industry share a common goal in improving patient outcomes and this has been the foundation of Joint Working projects. The potential of such projects to deliver improvements that benefit patients has been proven in a range of services and therapies. Payments relating to Joint Working agreements will be disclosed via the company website and details will be given as to the NHS partner, the nature of the engagement and the amount paid. Such information is disclosed prior to the project starting and updated throughout the course of the project.